Table 1.
Baseline characteristics of patients.
| Variables | All (n = 63) | PE group (n = 31) | NPE group (n = 32) | P value* |
|---|---|---|---|---|
| Age at diagnosis, years | 40.92 ± 10.89 | 41.45 ± 11.32 | 40.41 ± 10.63 | 0.71 |
| Course of HE, months | 15.49 ± 12.21 | 17.70 ± 14.49 | 13.35 ± 9.22 | 0.16 |
| Female | 11 (17.5%) | 4 (12.9%) | 7(21.9%) | 0.35 |
| BMI, Kg/m2 | 24.47 ± 2.10 | 25.55 ± 1.79 | 23.43 ± 1.85 | <0.01 |
| Medical histories | ||||
| Using CS before thrombosis | 31(49.2%) | 6(19.4%) | 25(78.1%) | <0.01 |
| Hypertension | 11(17.5%) | 3(9.7%) | 8(25.0%) | 0.11 |
| CAD | 1(3.1%) | 0(0%) | 1(3.1%) | 0.32 |
| Diabetes mellitus | 8(12.7%) | 3(9.7%) | 5(15.6%) | 0.48 |
| Hyperlipemia | 0(0%) | 0(0%) | 0(0%) | — |
| Allergy | 24(38.10%) | 12(44.4%) | 12(37.5%) | 0.59 |
| Smoking | 35(55.6%) | 20(64.5%) | 15(46.9%) | 0.16 |
| Drinking | 34(54.0%) | 15(48.4%) | 19(59.4%) | 0.38 |
| Blood routine test | ||||
| AEC on admission,109/L | 4.01 ± 3.29 | 5.13 ± 3.46 | 2.93 ± 2.76 | <0.01 |
| Peak AEC,109/L | 6.86 ± 3.64 | 8.46 ± 4.05 | 5.31 ± 2.38 | <0.01 |
| WBC on admission,109/L | 13.98 ± 5.54 | 15.96 ± 6.07 | 12.05 ± 4.26 | <0.01 |
| Hb on admission, g/L | 140.78 ± 18.71 | 143.718 ± 16.37 | 137.948 ± 20.58 | 0.22 |
| PLT on admission, 109/L | 166.89 ± 99.18 | 161.10 ± 90.98 | 172.50 ± 107.69 | 0.65 |
| Eosinophil infiltration | 45(71.4%) | 19(42.2%) | 26(57.8%) | 0.08 |
| Organ involvements | ||||
| Skin | 15(25.4%) | 7(22.6%) | 9(28.1%) | 0.61 |
| Heart | 9(14.3%) | 5(16.1%) | 4(12.5%) | 0.68 |
| Lung | 27(42.9%) | 10(32.3%) | 17(53.1%) | 0.09 |
| Kidney | 1(3.1%) | 0(0%) | 1(3.1%) | 0.32 |
| Gastrointestinal | 14(22.2%) | 8(25.8%) | 6(18.8%) | 0.50 |
| Lymph gland | 14(22.2%) | 6(19.4%) | 8(25.0%) | 0.59 |
| Muscle | 4(9.5%) | 2(6.5%) | 4(12.5%) | 0.41 |
| Peripheral nerve systems | 14(22.2%) | 9(29.0%) | 5(15.6%) | 0.20 |
Data are presented as mean ± standard deviation or n (%).
AEC, absolute eosinophil count; BMI, body mass index; CAD, coronary artery disease; CS, corticosteroid; HE, hypereosinophilia; Hb, haemoglobin; PE, pulmonary embolism; NPE, non-pulmonary embolism; PLT, platelet; WBC, white blood cell.